中国斜视与小儿眼科杂志
中國斜視與小兒眼科雜誌
중국사시여소인안과잡지
CHINESE JOURNAL OF STRABISMUS & PEDIATRIC OPHTHALMOLOGY
2014年
4期
19-21
,共3页
婴幼儿泪囊炎%泪道探通%典必殊眼膏
嬰幼兒淚囊炎%淚道探通%典必殊眼膏
영유인루낭염%루도탐통%전필수안고
infant dacryocystitis%probing of lacrimal passage%TobraDex eye ointment
目的：探讨泪道探通术联合泪道内注入典必殊眼膏法和单纯泪道探通术治疗不同年龄婴幼儿泪囊炎的临床疗效。方法对2012年7月至2013年11年我院眼科就诊的418例（454眼）婴幼儿泪囊炎患儿，按年龄3~6月龄、7~12月龄分为A、B两组，两组内随机分为泪道探通术联合泪道内注入典必殊眼膏组和单纯泪道探通术对照组进行治疗。结果 A组患儿总治愈率93.1%，其中泪道探通术联合泪道内典必殊眼膏组治愈率95.2%，对照组治愈率91.7%；B组总治愈率78.2%,泪道探通术联合泪道内注入典必殊眼膏组治愈率86.4%，对照组治愈率69.9%。总治愈率A组与B组间有显著性差异。两种泪道探通术的治愈率比较，A组内无显著性差异，B组内有显著性差异。结论3~6月龄是泪道探通术治疗婴幼儿泪囊炎最佳时机，6月龄以上患儿泪道探通联合泪道内注入典必殊眼膏能明显提高泪囊炎的治愈率。
目的：探討淚道探通術聯閤淚道內註入典必殊眼膏法和單純淚道探通術治療不同年齡嬰幼兒淚囊炎的臨床療效。方法對2012年7月至2013年11年我院眼科就診的418例（454眼）嬰幼兒淚囊炎患兒，按年齡3~6月齡、7~12月齡分為A、B兩組，兩組內隨機分為淚道探通術聯閤淚道內註入典必殊眼膏組和單純淚道探通術對照組進行治療。結果 A組患兒總治愈率93.1%，其中淚道探通術聯閤淚道內典必殊眼膏組治愈率95.2%，對照組治愈率91.7%；B組總治愈率78.2%,淚道探通術聯閤淚道內註入典必殊眼膏組治愈率86.4%，對照組治愈率69.9%。總治愈率A組與B組間有顯著性差異。兩種淚道探通術的治愈率比較，A組內無顯著性差異，B組內有顯著性差異。結論3~6月齡是淚道探通術治療嬰幼兒淚囊炎最佳時機，6月齡以上患兒淚道探通聯閤淚道內註入典必殊眼膏能明顯提高淚囊炎的治愈率。
목적：탐토루도탐통술연합루도내주입전필수안고법화단순루도탐통술치료불동년령영유인루낭염적림상료효。방법대2012년7월지2013년11년아원안과취진적418례（454안）영유인루낭염환인，안년령3~6월령、7~12월령분위A、B량조，량조내수궤분위루도탐통술연합루도내주입전필수안고조화단순루도탐통술대조조진행치료。결과 A조환인총치유솔93.1%，기중루도탐통술연합루도내전필수안고조치유솔95.2%，대조조치유솔91.7%；B조총치유솔78.2%,루도탐통술연합루도내주입전필수안고조치유솔86.4%，대조조치유솔69.9%。총치유솔A조여B조간유현저성차이。량충루도탐통술적치유솔비교，A조내무현저성차이，B조내유현저성차이。결론3~6월령시루도탐통술치료영유인루낭염최가시궤，6월령이상환인루도탐통연합루도내주입전필수안고능명현제고루낭염적치유솔。
Objective To compare the effect of probing of lacrimal passage combing injection of TobraDex eye ointment and probing of lacrimal passage for the treatment of infant dacryocystitis at different age. Methods From July 2012 to November 2013,418 patients (454 eyes) diagnosed in our Ophthalmology department were di-vided into two groups by age, group A aged 3 to 6 month old and group B aged 7 to 12 month old. The cases in each group randomly divided into observed group treated with TobraDex and control group. Results In this study, the total efficiency in group A was 93.1%, of which the observed group treated with TobraDex cure rate was 95.2% and control group was 91.7%; While the total efficiency in group B was 78.2%, of which the ob-served group treated with TobraDex cure rate was 86.4% and control group was 69.9%. The total cure rate had significant difference between group A and group B by age, also between observed group treated with TobraDex and control group in group B.But there was no significant difference between observed group treated with TobraDex and control group in group A.Conclusions The timing in probing of lacrimal passage with infant dacryocysitis was 3 to 6 month old. The probing of lacrimal passage combing TobraDex was more efficient when infant dacryocystitis over 6 month old.
